NOVOCURE LIMITED revenue breakdown overview

NOVOCURE LIMITED revenue for the last year amounted to 461.47 M EUR, the most of which — 461.47 M EUR — came from its highest performing source at the moment, Tumor Treating Fields, the year earlier bringing 502.54 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought NOVOCURE LIMITED 316.87 M EUR, and the year before that — 380.19 M EUR.